Urofollitropin: Difference between revisions
m Protected "Urofollitropin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
Line 1: | Line 1: | ||
Line 28: | Line 28: | ||
{{Sex hormones}} | {{Sex hormones}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Hormonal agents]] | [[Category:Hormonal agents]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 17:15, 20 August 2012
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C975H1513N267O304S26 |
Molar mass | 22672.9 g/mol |
WikiDoc Resources for Urofollitropin |
Articles |
---|
Most recent articles on Urofollitropin Most cited articles on Urofollitropin |
Media |
Powerpoint slides on Urofollitropin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Urofollitropin at Clinical Trials.gov Trial results on Urofollitropin Clinical Trials on Urofollitropin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Urofollitropin NICE Guidance on Urofollitropin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Urofollitropin Discussion groups on Urofollitropin Patient Handouts on Urofollitropin Directions to Hospitals Treating Urofollitropin Risk calculators and risk factors for Urofollitropin
|
Healthcare Provider Resources |
Causes & Risk Factors for Urofollitropin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Urofollitropin (brand names Bravelle®, Fertinex®, Follistim®, and Gonal-F®)is a purified form of follicle-stimulating hormone (FSH). FSH is important in the development of follicles (eggs) produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. It is also used with in vitro fertilization methods. The dosage is adjusted to each individual's response.
Its side effects include breast tenderness, mild diarrhea, nausea, or vomiting.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Endocrinology
- Hormonal agents